tiprankstipranks
Trending News
More News >
Entrada Therapeutics Inc (TRDA)
NASDAQ:TRDA
US Market

Entrada Therapeutics Inc (TRDA) Income Statement

Compare
149 Followers

Entrada Therapeutics Inc Income Statement

Last quarter (Q4 2025), Entrada Therapeutics Inc's total revenue was $1.30M, a decrease of -96.53% from the same quarter last year. In Q4, Entrada Therapeutics Inc's net income was $-39.16M. See Entrada Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 25.42M$ 210.78M$ 129.01M$ 0.00$ 0.00
Gross Profit
$ 21.32M$ 210.78M$ 129.01M$ 0.00$ 0.00
Operating Expenses
$ 177.32M$ 163.77M$ 132.18M$ 97.25M$ 51.13M
Depreciation and Amortization
$ 425.00K$ 3.77M$ 2.84M$ 1.90M$ 1.12M
EBITDA
$ -142.40M$ 47.01M$ -321.00K$ -95.35M$ -50.01M
Operating Income
$ -156.00M$ 47.01M$ -3.16M$ -97.25M$ -51.13M
Other Income/Expenses
$ 13.17M$ 19.47M$ 15.22M$ 2.63M$ -31.00K
Pretax Income
$ -142.83M$ 66.48M$ 12.06M$ -94.62M$ -51.16M
Net Income
$ -143.75M$ 65.63M$ -6.68M$ -94.62M$ -51.16M
Per Share Metrics
Basic EPS
$ -3.47$ 1.76$ -0.20$ -2.79$ -1.60
Diluted EPS
$ -3.47$ 1.68$ -0.20$ -2.79$ -1.60
Weighted Average Shares Outstanding
41.37M 37.31M 33.05M 31.29M 31.22M
Weighted Average Shares Outstanding (Diluted)
41.37M 39.00M 33.05M 31.29M 31.22M
Currency in USD

Entrada Therapeutics Inc Earnings and Revenue History